rs3751662
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_021098.3(CACNA1H):c.300-8G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000234 in 1,604,724 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00024 ( 1 hom. )
Consequence
CACNA1H
NM_021098.3 splice_region, intron
NM_021098.3 splice_region, intron
Scores
2
Splicing: ADA: 0.0001985
1
Clinical Significance
Conservation
PhyloP100: -1.15
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 16-1194964-G-A is Benign according to our data. Variant chr16-1194964-G-A is described in ClinVar as [Benign]. Clinvar id is 767495.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000204 (31/152238) while in subpopulation EAS AF= 0.00562 (29/5156). AF 95% confidence interval is 0.00402. There are 0 homozygotes in gnomad4. There are 19 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 31 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.300-8G>A | splice_region_variant, intron_variant | Intron 2 of 34 | 1 | NM_021098.3 | ENSP00000334198.7 | |||
CACNA1H | ENST00000565831.6 | c.300-8G>A | splice_region_variant, intron_variant | Intron 1 of 32 | 1 | ENSP00000455840.1 | ||||
CACNA1H | ENST00000638323.1 | c.299-7G>A | splice_region_variant, intron_variant | Intron 2 of 34 | 5 | ENSP00000492267.1 | ||||
CACNA1H | ENST00000639478.1 | n.299-7G>A | splice_region_variant, intron_variant | Intron 2 of 34 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.300-8G>A | splice_region_variant, intron_variant | Intron 2 of 34 | 5 | ENSP00000491488.1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152120Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
31
AN:
152120
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000473 AC: 117AN: 247178Hom.: 0 AF XY: 0.000423 AC XY: 57AN XY: 134660
GnomAD3 exomes
AF:
AC:
117
AN:
247178
Hom.:
AF XY:
AC XY:
57
AN XY:
134660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000237 AC: 344AN: 1452486Hom.: 1 Cov.: 31 AF XY: 0.000217 AC XY: 157AN XY: 723032
GnomAD4 exome
AF:
AC:
344
AN:
1452486
Hom.:
Cov.:
31
AF XY:
AC XY:
157
AN XY:
723032
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000204 AC: 31AN: 152238Hom.: 0 Cov.: 30 AF XY: 0.000255 AC XY: 19AN XY: 74432
GnomAD4 genome
AF:
AC:
31
AN:
152238
Hom.:
Cov.:
30
AF XY:
AC XY:
19
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 08, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at